benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet
benazepril hydrochloride
RxCUI: 898372
What the CMS Formulary Data Shows for benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet
Per the CMS 2026 Part D formulary file, benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet (RxNorm concept RXCUI 898372, generic name benazepril hydrochloride) appears on 326 distinct formulary files spanning 4,949 Medicare Part D plan offerings - 97.7% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.4.
Real-world access to benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 12.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 540,761 Part D beneficiaries filled benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $37,037,536 and an average per-beneficiary annual cost of $68.49. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 326
- Plans covering
- 4,949
- Coverage rate
- 97.7%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 12.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 540,761
- Total spending
- $37,037,536
- Avg per beneficiary
- $68.49
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet covered by Medicare Part D?
Yes, benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet is covered by 4,949 Medicare Part D plans (97.7% of all Part D formularies).
What tier is benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet on Medicare Part D plans?
benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet averages Tier 2.4 across Part D plans, ranging from Tier 1 to Tier 6.
Does benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet. Step therapy: 0%. Quantity limits: 12.9%.
How much does Medicare spend on benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet?
In 2023, total Medicare Part D spending on benazepril hydrochloride 20 MG / hydrochlorothiazide 25 MG Oral Tablet was $37,037,536, covering 540,761 beneficiaries. The average spend per beneficiary was $68.49.
Read our methodology - how this data is sourced, computed, and verified.